OPG
Also called: osteoprotegerin, OPG/RANKL ratio
What it means
OPG (osteoprotegerin) is a protein made by bone-building cells that blocks a signal called RANKL, which helps slow down bone breakdown.
The balance between OPG and RANKL helps determine whether your bones are breaking down faster than they're rebuilding, especially around menopause.
OPG, short for osteoprotegerin, is a protein your bone-building cells (osteoblasts) make to help control how much bone breakdown happens. Think of it as a decoy: it grabs onto a signal called RANKL before RANKL can reach the receptor on cells that break down bone, called osteoclasts. Less RANKL getting through means less bone resorption.
The balance between RANKL and OPG is a big part of what decides whether your bones are gaining or losing ground at any given time. Estrogen plays a key role here, it boosts OPG and lowers RANKL, which is one reason bone loss speeds up after menopause when estrogen drops and the RANKL/OPG ratio shifts toward more breakdown.
This same pathway is also the target of a prescription medication, denosumab, which works like a man-made version of OPG by binding RANKL to reduce bone breakdown. Because stopping this medication can lead to a rebound in bone turnover, any decisions about starting, continuing, or stopping it should be made with your doctor.
OPG blocks the RANKL signal, and this OPG-RANKL balance shapes whether bones gain or lose density, especially at menopause.
Where this leads
WordOPG works by blocking RANKL. Curious what RANKL actually does and why it is such a key target for osteoporosis treatments?
Where the Academy teaches it
This page is the short version. The lessons teach it in full, with the context around it and a quiz to lock it in.
Related words
RANKL is a signal that activates osteoclasts, the cells that break down bone, and it's a key target for some…
RANK is a protein on bone-cell precursors that, when activated, tells them to turn into osteoclasts, the cells that…
Osteoclastogenesis is the process where bone marrow cells turn into osteoclasts, the cells responsible for breaking…
Denosumab (Prolia) is a twice-yearly injection that blocks RANKL, a signal osteoclasts need to mature, slowing bone…
Estrogen is a hormone that protects bone by keeping bone-removing cells in check. Falling estrogen, especially at…
Bone remodeling is the lifelong cycle where cells called osteoclasts remove old bone and osteoblasts build new bone…
Education only, not medical advice. Decisions about tests, medications and treatment belong with your own doctor. OsteoStrong does not diagnose, treat or cure any disease.
